Antiphospholipid syndrome (APS) is an autoimmune antibody-mediated condition
characterized by thrombotic events and/or pregnancy morbidity in association with persistent …

Neurological involvement in antiphospholipid antibody syndrome (APS) is common, and its
occurrence increases morbidity and mortality. Patients may present variable neurological …

The antiphospholipid syndrome (APS) was fully recognized as a clinical entity in the early
1980s. Still, more than 30 years later, the epidemiology of APS is not well described, and …

Antiphospholipid syndrome (APS) is a common autoimmune pro-thrombotic condition
characterised by thrombosis and pregnancy morbidity. There are a broad range of …

Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but highly morbid
complication after adenoviral vector-based SARS-CoV-2 vaccination. The pre-VITT …

Abstract Purpose of Review The purpose of this report is to review recent research findings
on APS in children and neonates. Recent Findings European evidence-based …

Primary antiphospholipid syndrome (PAPS) and antiphospholipid syndrome associated to
lupus (SAPS) have several overlap** characteristics. As systemic manifestations are also …

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder mainly characterised
by increased risks of thrombosis and pregnancy morbidity and persistent positive test results …

Background: For more than a century, scientists have investigated the pathophysiology of
migraine and debated on various mechanisms of pathogenesis, ranging from the vascular …

While the classification criteria for definite antiphospholipid syndrome (APS) include specific
thrombotic and obstetric manifestation, there are numerous clinical features also present in …